Swiss consensus on the role of DHEA in the management of genitourinary syndrome of menopause.

Stute, P; Bertschy, S; Birkhaeuser, M; Bitzer, J; Ging, A; Raggi, A; Steimann, S; Stute, V (2022). Swiss consensus on the role of DHEA in the management of genitourinary syndrome of menopause. Climacteric, 25(3), pp. 246-256. Taylor & Francis 10.1080/13697137.2021.2008894

Full text not available from this repository.

Genitourinary syndrome of menopause (GSM) has a significantly negative impact on affected women's lives. However, despite the increasing number of GSM treatment options (e.g. non-hormonal vaginal products, vaginal hormones [estrogens], dehydroepiandrosterone [DHEA; prasterone], vaginal laser therapy, oral ospemifene), many women remain untreated. The goal of the Swiss interdisciplinary GSM consensus meeting was to develop tools for GSM management in daily practice: a GSM management algorithm (personalized medicine); a communication tool for vaginal DHEA (drug facts box); and a communication tool for understanding regulatory authorities and the discrepancy between scientific data and package inserts. The acceptance and applicability of such tools will be further investigated.

Item Type:	Journal Article (Review Article)
Division/Institute:	04 Faculty of Medicine > University Psychiatric Services > University Hospital of Psychiatry and Psychotherapy > Translational Research Center 04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Gynaecology
UniBE Contributor:	Stute, Petra, Ging, Ankica
Subjects:	600 Technology > 610 Medicine & health
ISSN:	1473-0804
Publisher:	Taylor & Francis
Language:	English
Submitter:	Monika Zehr
Date Deposited:	02 Feb 2022 11:34
Last Modified:	05 Dec 2022 16:01
Publisher DOI:	10.1080/13697137.2021.2008894
PubMed ID:	34907824
Uncontrolled Keywords:	Genitourinary syndrome of menopause drug facts box interdisciplinary consensus personalized treatment prasterone vaginal estrogen
URI:	https://boris.unibe.ch/id/eprint/163883